Literature DB >> 32482792

Molecular Imaging of Cardiac Amyloidosis.

Ahmad Masri1, Syed Bukhari2, Yvonne S Eisele2, Prem Soman3.   

Abstract

Transthyretin and light-chain amyloidosis are the 2 main causes of cardiac amyloidosis. Recent developments in molecular imaging have transformed our ability to diagnose transthyretin cardiac amyloidosis noninvasively and unmasked a hitherto unrecognized prevalence of the disease. This review summarizes the current and evolving imaging approaches, their molecular structural basis, and the gaps in imaging capabilities that have arisen as a result of parallel developments in pharmacotherapy delivering the first effective treatment options for this condition.
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  ATTR; SPECT; bone-seeking tracers; cardiac amyloidosis; molecular imaging

Mesh:

Year:  2020        PMID: 32482792      PMCID: PMC9374028          DOI: 10.2967/jnumed.120.245381

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   11.082


  40 in total

1.  Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.

Authors:  Jonathan S Wall; Stephen J Kennel; Alan C Stuckey; Misty J Long; David W Townsend; Gary T Smith; Karen J Wells; Yitong Fu; Michael G Stabin; Deborah T Weiss; Alan Solomon
Journal:  Blood       Date:  2010-06-03       Impact factor: 22.113

Review 2.  Molecular mechanism of Thioflavin-T binding to amyloid fibrils.

Authors:  Matthew Biancalana; Shohei Koide
Journal:  Biochim Biophys Acta       Date:  2010-04-22

3.  Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study.

Authors:  W Phillip Law; William Y S Wang; Peter T Moore; Peter N Mollee; Arnold C T Ng
Journal:  J Nucl Med       Date:  2016-06-15       Impact factor: 10.057

4.  11C-Pittsburgh B PET imaging in cardiac amyloidosis.

Authors:  Seung-Pyo Lee; Eun Seong Lee; Hongyoon Choi; Hyung-Jun Im; Youngil Koh; Min-Ho Lee; Ji-Hyun Kwon; Jin Chul Paeng; Hyung-Kwan Kim; Gi Jeong Cheon; Yong-Jin Kim; Inho Kim; Sung-Soo Yoon; Jeong-Wook Seo; Dae-Won Sohn
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-04

5.  18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.

Authors:  Mi-Ae Park; Robert F Padera; Anthony Belanger; Shipra Dubey; David H Hwang; Vikas Veeranna; Rodney H Falk; Marcelo F Di Carli; Sharmila Dorbala
Journal:  Circ Cardiovasc Imaging       Date:  2015-08       Impact factor: 7.792

Review 6.  Cardiac amyloidosis: pathology, nomenclature, and typing.

Authors:  Joseph J Maleszewski
Journal:  Cardiovasc Pathol       Date:  2015-08-01       Impact factor: 2.185

7.  Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.

Authors:  Maria Beatrice Musumeci; Francesco Cappelli; Domitilla Russo; Giacomo Tini; Marco Canepa; Agnese Milandri; Rachele Bonfiglioli; Gianluca Di Bella; Filomena My; Marco Luigetti; Marina Grandis; Camillo Autore; Stefano Perlini; Federico Perfetto; Claudio Rapezzi
Journal:  JACC Cardiovasc Imaging       Date:  2019-12-18

8.  Epidemiology of AL amyloidosis: a real-world study using US claims data.

Authors:  Tiffany P Quock; Tingjian Yan; Eunice Chang; Spencer Guthrie; Michael S Broder
Journal:  Blood Adv       Date:  2018-05-22

9.  Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure.

Authors:  Timothy C Wong; Kayla M Piehler; Karolina M Zareba; Kathie Lin; Ashley Phrampus; Agam Patel; James C Moon; Martin Ugander; Uma Valeti; Jonathan E Holtz; Bo Fu; Chung-Chou H Chang; Michael Mathier; Peter Kellman; Javed Butler; Mihai Gheorghiade; Erik B Schelbert
Journal:  J Am Heart Assoc       Date:  2013-11-18       Impact factor: 5.501

10.  (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.

Authors:  Björn Pilebro; Ole B Suhr; Ulf Näslund; Per Westermark; Per Lindqvist; Torbjörn Sundström
Journal:  Ups J Med Sci       Date:  2016-02-05       Impact factor: 2.384

View more
  7 in total

Review 1.  Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens.

Authors:  Peili Cen; Youyou Zhou; Chunyi Cui; Yen Wei; Zhen Cheng; Shuizhu Wu; Hong Zhang; Mei Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-04       Impact factor: 9.236

Review 2.  New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy.

Authors:  Roxana Cristina Rimbas; Anca Balinisteanu; Stefania Lucia Magda; Simona Ionela Visoiu; Andrea Olivia Ciobanu; Elena Beganu; Alina Ioana Nicula; Dragos Vinereanu
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

3.  Diagnostic performance of CMR, SPECT, and PET imaging for the detection of cardiac amyloidosis: a meta-analysis.

Authors:  Zhaoye Wu; Chunjing Yu
Journal:  BMC Cardiovasc Disord       Date:  2021-10-07       Impact factor: 2.298

Review 4.  Conceptualising centres of excellence: a scoping review of global evidence.

Authors:  Tsegahun Manyazewal; Yimtubezinash Woldeamanuel; Claire Oppenheim; Asrat Hailu; Mirutse Giday; Girmay Medhin; Anteneh Belete; Getnet Yimer; Asha Collins; Eyasu Makonnen; Abebaw Fekadu
Journal:  BMJ Open       Date:  2022-02-07       Impact factor: 2.692

5.  Reliability and feasibility of visual grading systems and quantitative indexes on [99mTc]Tc-DPD imaging for cardiac amyloidosis.

Authors:  Sungwoo Bae; Joonhyung Gil; Jin Chul Paeng; Eun-Ah Park; Seung-Pyo Lee; Hongyoon Choi; Keon Wook Kang; Gi Jeong Cheon; Dong Soo Lee
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

6.  Pilot Study of F18-Florbetapir in the Early Evaluation of Cardiac Amyloidosis.

Authors:  Brett W Sperry; Ashley Bock; Frank P DiFilippo; Joseph P Donnelly; Mazen Hanna; Wael A Jaber
Journal:  Front Cardiovasc Med       Date:  2021-06-25

Review 7.  Absolute Quantification in Diagnostic SPECT/CT: The Phantom Premise.

Authors:  Stijn De Schepper; Gopinath Gnanasegaran; John C Dickson; Tim Van den Wyngaert
Journal:  Diagnostics (Basel)       Date:  2021-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.